



| Product name | Abrocitinib |
| Cas number | 1622902-68-4 |
| Appearance | White powder |
| MF | C14H21N5O2S |
| MW | 323.42 |
PF-04965842 (Abrotinib) has achieved positive results in multiple phase 3 clinical trials targeting patients with moderate to severe atopic dermatitis. It has shown statistically significant improvements in skin symptom clearance rate and disease severity, and rapidly improves itching symptoms in patients compared to placebo.
















Audited Supplier









